-
FEBRASGO POSITION STATEMENT12-11-2023
Trauma and pregnancy: Number 10 – October 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(10):622-631
Abstract
FEBRASGO POSITION STATEMENTTrauma and pregnancy: Number 10 – October 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(10):622-631
-
FEBRASGO POSITION STATEMENT09-08-2023
Operative vaginal delivery: Number 7 – July 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(7):422-434
Abstract
FEBRASGO POSITION STATEMENTOperative vaginal delivery: Number 7 – July 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(7):422-434
-
FEBRASGO POSITION STATEMENT08-07-2023
Cervical cancer in pregnancy
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(5):293-296
Abstract
FEBRASGO POSITION STATEMENTCervical cancer in pregnancy
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(5):293-296
-
FEBRASGO POSITION STATEMENT08-04-2023
Misoprostol use in obstetrics: Number 6 – June 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(6):356-367
Abstract
FEBRASGO POSITION STATEMENTMisoprostol use in obstetrics: Number 6 – June 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(6):356-367
-
FEBRASGO POSITION STATEMENT07-10-2023
Fertility preservation in gynecologic cancer patients
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(3):161-167
Abstract
FEBRASGO POSITION STATEMENTFertility preservation in gynecologic cancer patients
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(3):161-167
Views175Background Gynecological cancer directly affects fertility, as treatment consists of surgical removal of the reproductive system and/or exposure to gonadotoxic agents. However, patients in early stages who meet established criteria can be treated with fertility-sparing surgeries and reach equivalent oncological results to those of traditional treatments. Fertility preservation techniques such as cryopreservation of oocytes, embryos […]See more -
FEBRASGO POSITION STATEMENT07-10-2023
Guidelines on how to monitor gestational weight gain during antenatal care: Number 2 – February 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(2):104-108
Abstract
FEBRASGO POSITION STATEMENTGuidelines on how to monitor gestational weight gain during antenatal care: Number 2 – February 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(2):104-108
-
FEBRASGO POSITION STATEMENT06-30-2023
Accurate diagnosis of breast lesions Number 4 – April 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(4):215-219
Abstract
FEBRASGO POSITION STATEMENTAccurate diagnosis of breast lesions Number 4 – April 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(4):215-219
-
FEBRASGO POSITION STATEMENT04-14-2023
Prediction and prevention of preeclampsia Number 1 – January 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(1):49-54
Abstract
FEBRASGO POSITION STATEMENTPrediction and prevention of preeclampsia Number 1 – January 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(1):49-54